INTRODUCTION
Acute and chronic pituitary failure has been described in patients envenomed by the Burmese Russell's viper. Clinical features of hypopituitarism, such as lack of response of plasma growth hormone (GH) to insulininduced hypoglycaemia, were documented in 30% of patients who had apparently recovered from snake bites (Tun-Pe, Warrell, Tin-Nu-Swe et al. 1987) . Chronic hypopituitarism has also been described in three patients bitten by Russell's vipers in India (Eapen, Chandy, Kochuvarkey et al. 1976 ).
In Burma, pituitary haemorrhage was a frequent necropsy finding in patients who died after envenoming (Aung-Khin, 1977) . This description of haemorrhagic necrosis of the pituitary has led to the suggestion that the pituitary failure seen in these patients resembles that of post-partum pituitary necrosis (Sheehan's syn¬ drome) . In this syndrome, post-partum haemorrhage, with its attendant shock and frequent coagulation abnormalities, is thought to precipitate ischaemic necrosis (Sheehan, 1940 (Fig. 1) . Venom, at a concentration of 0-1 pg/ml, had no significant effect on GH secretion. However, higher concentrations of venom (1 and 10 pg/ml) stimulated GH release by 192% (P<002) and 344% (P<0001) respectively, compared with the basal value. Similarly, venom caused a significant increase in ACTH release at con¬ centrations of 1 pg/ml (301%, P<0-02) and 10 pg/ml (>700% The effect of SRIF (10 and 100 ng/ml) on venomstimulated GH release from perifused rat pituitary cells is shown in Fig. 4 . Basal GH release without the addition of SRIF averaged 100 pg/1. An initial peri¬ fusion with GRF (1 nmol/1) caused a 600% increase in GH release from both columns. The subsequent two additions of GRF (1 nmol/1), which also stimulated GH release by approximately 600%, were completely abolished by SRIF (10 and 100 ng/ml respectively). The first addition of venom (1 pg/ml) caused a 1000% increase in GH release, which was not affected by SRIF (10 ng/ml). Subsequent additions of venom, which exhibited the previously noted reduced stimula¬ tory effect on GH release, were also not affected by SRIF (100 ng/ml). Results were repeated using the pure preparation of Burmese Russell's viper venom and equivalent results obtained. figure 4. Effect of somatostatin on GH-releasing factor (GRF)-and venom-stimulated GH secretion from perifused rat anterior pituitary cells. Cells were dispersed as described in Materials and Methods and divided to form two peri¬ fusion columns which were run in parallel. To the first column (upper panel) GRF (1 nmol/1) and venom (1 pg/ml) were added alternately as shown by the arrows. To the second column (lower panel) the same concentrations of GRF and venom were added with the addition of 10 or 100 ng somatostatin/ml (horizontal bar). This figure is representative of four similar experiments.
DISCUSSION
In the present study, cultured rat anterior pituitary cells were highly responsive to increasing concen¬ trations of venom (0-1-10 pg/ml), which produced a rise in GH, ACTH (Wehrenberg, Ling, Brazeau et al. 1982) and in vitro (Bilezikjian & Vale, 1984; Ceda & Hoffman, 1985; Bilezikjian, Seifert & Vale, 1986) . This 'desensitization' has been thought to be partly due to the depletion of the pool of releasable GH, a marked decrease in pituitary GH content being seen after prolonged exposure to GRF in vitro (Ceda & Hoffman, 1985) . However, our results (Fig. 3) . also show that the pituitary cells retain their full ability to respond to GRF and KCl, even though the GH response to venom has been attenuated. This would indicate that the reduction in the GH response to venom is not due to GH pool depletion. It has been reported that the decrease in apparent sensitivity to GRF may be due to the down-regulation of GRF binding sites (Bilezikjian et al. 1986 ) and/or an impair¬ ment of the coupling of a component of the adenylate cyclase system (Simard & Labrie, 1986) . However, the ability of GRF to stimulate GH release after desensitization with venom suggests that the venom is impairing an alternative mechanism.
Somatostatin, the physiological inhibitor of GH release, abolished GRF-stimulated GH release from perifused pituitary cells, but had no effect on venomstimulated GH release (Fig. 4) . The inhibition of GH release by SRIF has been shown to be, at least in part, due to its inhibitory effect on adenylate cyclase (Bilezikjian & Vale, 1983; Harwood, Grewe & Aguilera, 1984 (Deems & Dennis, 1981) and trypsinization (De Haas, Slotboom, Bonsen & Van Deenan, 1970 
